BRADLEY FOSTER & SARGENT INC/CT Novo Nordisk A/S Transaction History

BRADLEY FOSTER & SARGENT INC/CT portfolio value:

$3.62M
portfolio value

BRADLEY FOSTER & SARGENT INC/CT quarter portfolio value change:

-10.59%
quarter

Novo Nordisk A/S 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -0.59% -215 shares -454K $99.63 36.40K
Q2 2022 share Increase +1.89% 680 shares 90K $111.43 36.62K
Q1 2022 share Decrease -0.42% -150 shares -51K $111.05 35.94K
Q4 2021 share Decrease -1.47% -537 shares 525K $111.45 36.09K
Q3 2021 share Increase +1.13% 408 shares 483K $96.01 36.62K
Q2 2021 share Increase +1.72% 612 shares 633K $83.32 36.22K
Q1 2021 share Decrease -0.20% -71 shares -91K $67.06 35.60K
Q4 2020 share Increase +1.28% 450 shares 46K $68.52 35.68K
Q3 2020 share Increase +0.25% 89 shares 331K $68.1 35.23K
Q1 2020 share Decrease -0.07% -25 shares 80K $58.59 35.14K
Q4 2019 share Increase +0.99% 345 shares 235K $55.56 35.16K
Q3 2019 share Decrease -1.49% -525 shares -4K $49.63 34.82K
Q2 2019 share Decrease -6.36% -2.4K shares -170K $48.57 35.34K
Q1 2019 share 0.00% 0 shares 235K $49.78 37.74K
Q4 2018 share Decrease -3.82% -1.5K shares -111K $43.17 37.74K
Q3 2018 share Increase +571.33% 33.4K shares 1.58M $44.17 39.24K
Q2 2018 share 0.00% 0 shares -18K $43.22 5.84K
Q1 2018 share Increase +0.36% 21 shares -25K $46.15 5.84K
Q4 2017 share Decrease -7.42% -467 shares 10K $49.61 5.82K
Q3 2017 share Decrease -2.01% -129 shares 28K $44.5 6.29K
Q2 2017 share Increase 0.00% 6.42K shares 275K $39.35 6.42K
Q1 2017 share Decrease -100.00% -8.30K shares -298K $31.45 0
Q4 2016 share Decrease -79.63% -32.45K shares -1.39M $32.43 8.30K
Q3 2016 share Increase +4.01% 1.57K shares -413K $37.61 40.75K
Q2 2016 share Increase +1.71% 658 shares 20K $48.3 39.18K
Q1 2016 share Increase +8.78% 3.11K shares 31K $48.66 38.53K